UK markets open in 43 minutes
NIKKEI 225
38,411.74 +859.58 (+2.29%) HANG SENG
17,184.12 +355.19 (+2.11%) CRUDE OIL
83.47 +0.11 (+0.13%) GOLD FUTURES
2,342.10 0.00 (0.00%) DOW
38,503.69 +263.71 (+0.69%) Bitcoin GBP
53,554.79 +42.16 (+0.08%)
SK Inc. (034730.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
At close: 02:57PM KST
| Previous close | 160,700.00 |
| Open | 162,500.00 |
| Bid | 162,700.00 x 0 |
| Ask | 162,800.00 x 0 |
| Day's range | 161,500.00 - 164,200.00 |
| 52-week range | 134,700.00 - 212,000.00 |
| Volume | |
| Avg. volume | 211,675 |
| Market cap | 8.87T |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | 5,000.00 (3.11%) |
| Ex-dividend date | 29 Mar 2024 |
| 1y target est | 250,000.00 |
PR NewswireSK E&S, strengthening 'Low-Carbon Hydrogen Partnership' at COP28... accelerating global carbon neutrality
SK E&S has collaborated with global partners to establish foundation for the domestic low-carbon hydrogen* industry, with support from local government. They plan to mass-produce low-carbon hydrogen, leading the early establishment of the domestic hydrogen ecosystem and contributing to global carbon neutrality.
PR NewswireSK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
SK pharmteco will participate at the CPHI 2023 in Barcelona and prepare a dedicated booth at the event. As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pursue business opportunities.
© 2024 Yahoo. All rights reserved.